Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7712.62 | 1445 / 1445 | 100% | 55.30 | 183 / 183 |
stomach | 100% | 6292.54 | 359 / 359 | 100% | 42.67 | 285 / 286 |
intestine | 100% | 7408.75 | 966 / 966 | 99% | 40.70 | 524 / 527 |
thymus | 100% | 11288.24 | 653 / 653 | 99% | 55.03 | 600 / 605 |
brain | 99% | 8684.28 | 2628 / 2642 | 99% | 49.32 | 699 / 705 |
lung | 100% | 12218.66 | 578 / 578 | 99% | 39.18 | 1139 / 1155 |
kidney | 100% | 5874.20 | 89 / 89 | 98% | 42.35 | 879 / 901 |
breast | 100% | 7283.34 | 459 / 459 | 96% | 30.89 | 1077 / 1118 |
skin | 99% | 10191.84 | 1799 / 1809 | 97% | 37.13 | 457 / 472 |
ovary | 97% | 4860.48 | 175 / 180 | 97% | 31.50 | 418 / 430 |
uterus | 99% | 5829.95 | 169 / 170 | 95% | 30.67 | 436 / 459 |
pancreas | 95% | 7085.73 | 313 / 328 | 97% | 38.63 | 173 / 178 |
prostate | 98% | 3897.06 | 241 / 245 | 88% | 19.06 | 440 / 502 |
bladder | 100% | 5524.38 | 21 / 21 | 82% | 22.68 | 412 / 504 |
adrenal gland | 91% | 4022.98 | 235 / 258 | 80% | 41.01 | 185 / 230 |
liver | 83% | 3178.05 | 188 / 226 | 87% | 21.14 | 353 / 406 |
blood vessel | 100% | 8910.50 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 61.60 | 29 / 29 |
spleen | 100% | 10776.31 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 8025.88 | 1202 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 6277.90 | 847 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 56.61 | 44 / 45 |
muscle | 98% | 6628.82 | 783 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 45.01 | 78 / 80 |
peripheral blood | 93% | 9491.56 | 868 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0045647 | Biological process | negative regulation of erythrocyte differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | KLF13 |
Protein name | Krueppel-like factor 13 Kruppel-like factor 13 KLF transcription factor 13 Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Novel Sp1-like zinc finger transcription factor 1) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3) (Transcription factor NSLP1) Kruppel-like factor 13 isoform B |
Synonyms | hCG_38887 NSLP1 BTEB3 |
Description | FUNCTION: Represses transcription by binding to the BTE site, a GC-rich DNA element, in competition with the activator SP1. It also represses transcription by interacting with the corepressor Sin3A and HDAC1. Activates RANTES expression in T-cells. . |
Accessions | ENST00000621843.1 X5D2Z0 Q9Y2Y9 ENST00000560473.1 ENST00000616962.1 H0YK05 ENST00000558844.1 ENST00000307145.4 H0YKM8 X5DNR2 A0A087X1K6 |